PMWC Silicon Valley 2022


Stephane Mouradian

Stephane Mouradian, PhD
Senior Vice President, Business Development and Marketing
Personalis, Inc.

June 29, 2022 | 2:15 PM PDT

NeXT Personal: NextGen MRD Testing for Solid Tumors

The ability to monitor and predict molecular recurrence at the earliest timepoints during or after curative therapy in patients previously diagnosed with cancer may inform precision treatment regimens, or spare patients from costly side effects. Here we discuss NeXT Personal, an advanced next generation MRD platform optimized for sensitivity.

Connect with us at PMWC Silicon Valley 2022